12.9 C
New York
Tuesday, November 5, 2024

Pfizer is betting on next-gen cancer drugs to offset slowing demand for COVID vaccines

Pfizer is betting on next-gen cancer drugs to offset slowing demand for COVID vaccines

Pfizer expects cancer drugs developed by Seagen, the biotech company it acquired last year, to generate $10 billion in sales by 2030

By Bruce Gil, Quartz 

Pfizer (PFE) is betting that next-gen cancer therapies will be a key part of its business as demand for COVID vaccines continue to dwindle.

More here >

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

156,522FansLike
396,312FollowersFollow
2,320SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x